HOME > ATTORNEYS > Yuko MATSUTOYA　Partner, Patent Attorney

Yuko MATSUTOYA　　Partner, Patent Attorney
 
Yuko MATSUTOYA Partner, Patent Attorney

PRACTICE AREA
Biochemistry, Pharmaceuticals, Chemistry

ADMISSION／MEMBERSHIP
Japan Patent Attorneys Association (JPAA)
Licensing Executives Society Japan (LES)
Intellectual Property Association of Japan (JIPAJ)
 

EDUCATION ／WORK EXPERIENCE
 

WORK EXPERIENCE
Aug. 2016-2023

Visiting Senior Research Fellow,
TRI (Translational Research Center for Medical Innovation), FBRI

Dec. 2008-2021

Visiting Professor of Tohoku University

Jul. 2008-

OHNO & PARTNERS

Apr.2001-Jun.2008

HIRAKI & ASSOCIATES

Apr.1988-Mar.2001

Shiseido Company, Limited
Pharmaceutical Division, Licensing Group
Patent Department
 

EDUCATION
Mar. 1988

Master of Pharmaceutical Sciences (Immunology)
The University of Tokyo (Graduate School of Pharmaceutical Sciences)

Mar. 1986

Bachelor of Pharmaceutical Sciences
The University of Tokyo (Faculty of Pharmaceutical Sciences)
 

PUBLICATIONS
 

Publications (Books):

◆“Working of the patented invention for experimental or research purposes”
　 Judge Makiko TAKABE’s retirement commemorative theses “Chitekizaisanken-sosho no
　 kirameki” (The Glimmer of Intellectual Property Litigation), 2021 December, pp54-74
◆"The point of intellectual property right lawsuit (知的財産権訴訟要論)" (Patent), 7th Edit.
　 Minoru TAKEDA/Yuko MATSUTOYA, 2017 December, JIII
　 ISBN 978‐4‐8271‐1292‐4
◆"Medicine and Patent (医療と特許)" IIP Research Journal, Soeisha/Sanseido, 2017 April
　The ways of Patent Protection of Medical Invention/Yuko MATSUTOYA
　 ISBN 978-4-88142-126-0
　 　

Publications (Law Review Articles):

◆“Patentability of Product Claim reciting “Effect” as Element of Invention” Intellectual Property Management, Vol.83 No.6 (No.870), pp678-689, 2023 June
◆“Working of the patented invention for experimental or research purposes” Judge Makiko TAKABE’s retirement commemorative theses “Chitekizaisanken-sosho no kirameki” (The Glimmer of Intellectual Property Litigation), 2021 December, pp54-74
◆"Issues in patent law regarding CRISPR/Cas9 Patents - (3) Licensing and Patent pool"
　 The Invention Vo.116 No.2, pp65-69, 2019 February
◆"Issues in Patent Law regarding CRISPR/Cas9 Patents - (2) Priority under Paris Convention"
　The Invention Vo.116 No.1, pp47-51, 2019 January）
◆ "Gene Editing Tool CRISPR/Cas9 - Patent and Licensing Issues"
　 LES JAPAN NEWS Vol.59 No.4, pp19-28, 2018 December
◆"Issues in patent law regarding CRISPR/Cas9 patents - (1) First-to-file and Disclosure"
　 The Invention Vol.115 No.12, pp37-41, 2018 December
◆ "Regenerative medicine peripheral technology- IP of reagent and medium"
　 Pharm stage Vol.16 No.4, 2016 July
◆ "The status of IP in stem cell therapy: How to deal with patent infringement problem"
　 Clinical Evaluation, Vol.40, Suppl XXXI 2012
◆"IP Relay - Should genes be patentable subject matter? - Myriad v. AMP"
　 Pharm stage Vol.10 No.11, 2011 February, Yuko MATSUTOYA・Ryan B. Chirnomas）
◆ "[Discussion] Trilateral comparison in examination of stem cell patent applications"
　 Patent, Vol.62 No.8, 2009 July, Joint-Paper
◆ "International competitiveness and patent strategy in iPS cell technologies"
　 Journal of Intellectual Property Association of Japan, 6th Annual Meeting, 2008
　 Masaho ISHINO/Yuko MATSUTOYA
　 　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　etc.
 

LANGUAGES
Japanese, English

PAGE TOP
 
  • TRADEMARK&DESIGN
  • CHINESE INTELLECTUAL PROPERTY
  • BIOTECHNOLOGY
  • IP STRATEGY FOR BUSINESS
  • CAREERS
  • LINK